OneRNA® for Drug Development

About Genomic Expression

Genomic Expression is a Copenhagen-based biotech leveraging its OneRNA® platform to transform cancer care through comprehensive RNA analysis. The company's initial commercial application is in breast and ovarian cancer, where its test identifies multiple treatment options, including approved drug repurposing, for individual patients. Led by an experienced team, the company is transitioning from an angel-funded, grant-supported startup to raising a Series A to scale its diagnostic offerings and expand its pipeline into novel RNA therapeutic development. Its vision is to make AI-driven, RNA-based precision medicine a standard part of clinical care.

Therapeutic Areas

Other Oncology (Various) Drugs